Graft infection – Diagnostics – Overview of Information and Clinical Research

Graft infection is a serious complication that can occur when bacteria, viruses, or fungi invade a prosthetic graft used to replace or repair a blood vessel. Though uncommon, affecting roughly 1 to 5 percent of patients who receive vascular grafts, this condition demands urgent attention because it can lead to severe illness, limb loss, or even death if not promptly recognized and treated.

Introduction: Who Should Undergo Diagnostics and When

Anyone who has undergone surgery involving a vascular graft — a tube made of synthetic material used to replace or repair damaged arteries or veins — should be aware of the possibility of graft infection. While most people recover without complications, being alert to early warning signs is essential because graft infections can develop at any time: within weeks of surgery, months later, or even many years after the procedure.^[1]

If you experience fever, chills, night sweats, or unusual drainage from an old surgical incision — even if the surgery was performed years ago — it is crucial to seek medical evaluation immediately. These symptoms may indicate that bacteria have colonized the graft material and are causing an infection that needs prompt diagnosis and treatment.^[13] Early infections, those appearing within the first four months after graft placement, often involve more aggressive bacteria such as Staphylococcus aureus and produce obvious signs of illness including high fever and wound problems.^[1]

Late infections, occurring after four months, can be more subtle. They may result from bacteria that entered the body at the time of surgery but remained dormant, or from bacteria that traveled through the bloodstream from another infection site, such as a urinary tract infection or dental abscess.^[7] Because late infections are often caused by less aggressive organisms like coagulase-negative staphylococci, symptoms can be vague — perhaps just persistent low-grade fever, unexplained weight loss, or a general feeling of unwellness.^[1]

⚠️ Important

If you notice fever, chills, cloudy or foul-smelling drainage from any surgical incision (no matter how old), pain or redness around the graft site, or blue spots on your feet, go to the nearest emergency room immediately. Graft infections can progress rapidly and may become life-threatening if not treated promptly.^[5]

People at higher risk for graft infection include those with diabetes, chronic kidney disease, weakened immune systems, or obesity. Patients who had emergency surgery, repeat procedures, or operations involving incisions in the groin area also face increased risk.^[7] If you fall into any of these categories and have had vascular graft surgery, maintaining vigilant awareness of infection symptoms and seeking timely diagnostic evaluation is especially important.

Diagnostic Methods for Identifying Graft Infection

Diagnosing a graft infection is not always straightforward because symptoms can be subtle and may mimic other conditions. However, a combination of clinical examination, laboratory tests, and imaging studies helps doctors confirm whether a graft is infected and distinguish this from other problems.^[6]

Clinical Examination and Medical History

The diagnostic process typically begins with a thorough medical history and physical examination. Your doctor will ask about your surgical history, any recent infections elsewhere in your body, and symptoms you’ve experienced. During the physical exam, they will check for fever, examine any surgical scars for signs of infection such as redness, warmth, swelling, or discharge, and look for other physical signs like blue spots on the feet or abnormal pulses.^[5]

Laboratory Tests

Blood tests are essential in evaluating suspected graft infection. A white blood cell count, or WBC count, measures the number of infection-fighting cells in your blood. An elevated count often indicates that your body is responding to an infection.^[13] However, some patients with graft infection may have normal white blood cell counts, especially if the infection is chronic or low-grade.

Blood cultures may be taken to identify the specific bacteria causing the infection. This involves drawing blood samples and incubating them in a laboratory to see if bacteria grow. Identifying the organism helps doctors choose the most effective antibiotics.^[8] Common bacteria found in graft infections include Staphylococcus aureus and coagulase-negative staphylococci, which together account for about 35 percent of infections. Approximately 25 percent of graft infections involve multiple types of bacteria.^[8]

Imaging Studies

Imaging tests play a crucial role in diagnosing graft infections because they can show changes in and around the graft that suggest infection. Computed tomography, or CT scan, is one of the most commonly used imaging methods. A CT scan creates detailed cross-sectional images of the body and can reveal fluid collections around the graft, gas bubbles in soft tissues, or abnormal thickening of tissue surrounding the graft — all signs that may indicate infection.^[5]

Ultrasound is another valuable tool, particularly useful for examining grafts near the surface of the body. It uses sound waves to create images and can help detect fluid collections, abscesses, or changes in blood flow through the graft.^[13]

Traditional imaging sometimes cannot distinguish between infection and other post-surgical changes like inflammation or scar tissue. This is where specialized nuclear imaging becomes particularly helpful.

Advanced Nuclear Imaging

18F-FDG PET/CT, which stands for fluorodeoxyglucose positron emission tomography combined with computed tomography, is an advanced imaging technique that has proven highly reliable for diagnosing vascular graft infections. This test works by injecting a small amount of radioactive sugar into your bloodstream. Cells that are metabolically active — such as white blood cells fighting infection — take up more of this sugar and appear as bright spots on the scan.^[4]

Research has shown that FDG PET/CT is highly accurate for detecting graft infections. In one study of 39 patients with suspected vascular graft infection, this imaging method had a sensitivity of 93 percent (meaning it correctly identified 93 percent of actual infections), a specificity of 91 percent (meaning it correctly ruled out infection in 91 percent of cases without infection), and could accurately distinguish between infection in the graft itself versus infection in surrounding soft tissues.^[4]

The precise anatomic localization provided by combining PET with CT scanning helps doctors determine exactly where the infection is and whether it involves only the graft, only nearby tissues, or both. This information is critical for planning treatment.^[4]

Another nuclear imaging option is a white blood cell scan, also called a tagged WBC scan. For this test, white blood cells are separated from a sample of your blood, tagged with a radioactive marker, and returned to your bloodstream. These tagged cells naturally migrate to sites of infection, making those areas visible on special imaging.^[13]

Additional Imaging Options

Chest X-rays may be ordered if the graft is in the chest area, to look for fluid collections or other abnormalities around the graft.^[5] Magnetic resonance imaging, or MRI, can also be used in some cases, though it is employed less frequently than CT for graft infections.

Combining Multiple Tests

Often, doctors use several diagnostic methods in combination to build a complete picture. No single test is perfect on its own, but when clinical findings, laboratory results, and imaging studies all point toward infection, doctors can make a confident diagnosis and begin appropriate treatment.^[6] The specific combination of tests used depends on the location of the graft, how long ago surgery was performed, your symptoms, and what facilities are available at your medical center.

⚠️ Important

Diagnosing graft infection requires expertise and often multiple types of tests. A multidisciplinary team including vascular surgeons, infectious disease specialists, radiologists, and nuclear medicine physicians typically works together to reach an accurate diagnosis.^[7] If you suspect you have a graft infection, insist on being evaluated by specialists experienced in managing this serious complication.

Diagnostics for Clinical Trial Qualification

When patients with graft infections are considered for enrollment in clinical trials studying new treatments, diagnostic criteria become even more important. Clinical trials require precise, standardized methods to confirm that participants truly have the condition being studied and to measure how well treatments work.^[3]

For clinical trials involving graft infections, researchers typically establish strict diagnostic criteria that must be met before a patient can participate. These criteria often include specific combinations of clinical findings, laboratory results, and imaging evidence that together provide strong proof of infection.^[7]

Standard diagnostic criteria used in research settings commonly require documentation of fever or other systemic signs of infection, positive blood cultures or cultures from the surgical site identifying the infectious organism, and imaging evidence (usually CT or FDG PET/CT) showing characteristic features of graft infection such as fluid or gas around the graft, abnormal tissue thickening, or abnormal metabolic activity.^[4]

Clinical trials may also require confirmation that the infection involves the graft itself rather than just surrounding tissues. This is important because treatments and outcomes differ depending on whether the synthetic material is infected or whether infection is limited to adjacent soft tissues.^[4] FDG PET/CT is particularly valuable for making this distinction and is increasingly used as a qualification tool in research protocols studying graft infections.

Additional diagnostic requirements for trial enrollment might include microbiological confirmation of the specific bacteria or other organisms causing the infection, assessment of the severity of infection using standardized scoring systems, and documentation of any complications such as graft dysfunction, bleeding, or spreading infection.^[6]

Some trials require tissue samples obtained through biopsy or during surgery to definitively prove infection and identify the causative organisms. This provides the most certain diagnosis and helps researchers understand exactly which infections are being treated.^[6]

The timing of diagnosis is also important in clinical trial qualification. Some studies focus on early infections (within four months of graft placement) while others examine late infections (occurring more than four months post-surgery). Precise documentation of when the graft was placed and when symptoms began helps researchers assign patients to the appropriate study group.^[7]

Baseline diagnostic tests performed before treatment begins serve as reference points for measuring treatment response throughout the trial. Follow-up imaging and laboratory tests at specified intervals allow researchers to objectively assess whether infections are resolving, remaining stable, or progressing.^[3]

Because graft infections are relatively uncommon, clinical trials in this area often involve multiple medical centers working together. This requires standardization of diagnostic procedures across all participating sites to ensure that patients enrolled at different locations have comparable conditions. Central review of imaging studies and laboratory results by experts helps maintain diagnostic consistency throughout the study.^[3]

Prognosis and Survival Rate

Prognosis

The outlook for patients with graft infections depends on many factors, but overall this remains a very serious condition with significant risks. The location of the infected graft plays a major role in determining outcomes. Infections involving grafts in the aorta, the body’s largest artery, are particularly dangerous and carry the highest mortality rates.^[1] When infection affects grafts in the arms or legs, the risk to life may be somewhat lower, but the risk of losing the affected limb increases.^[1]

Several factors influence how well patients do after a graft infection is diagnosed. These include the virulence of the bacteria causing the infection, how quickly the infection is diagnosed and treated, the patient’s overall health and immune function, whether underlying conditions like diabetes or kidney disease are present, and whether complications such as bleeding, graft rupture, or widespread infection develop.^[3]

Patients with early infections caused by highly virulent bacteria like Staphylococcus aureus often become very ill very quickly but may respond better to aggressive treatment if caught early. Those with late, insidious infections caused by less aggressive organisms may have symptoms for months before diagnosis, which can allow the infection to become deeply established and harder to eradicate.^[1]

Even with optimal treatment, graft infections frequently result in long hospital stays, multiple surgeries, prolonged antibiotic therapy, and extended recovery periods. Many patients face permanent changes to their quality of life, including limitations in physical activity, chronic pain, or permanent disability.^[3]

Survival rate

Mortality, or death rates, from graft infections remain disturbingly high despite advances in medical care. Approximately one-third of all patients with vascular graft infections die from the infection or its complications.^[1] This means that roughly 33 percent of patients do not survive.

The mortality rate is highest when the infection involves grafts placed in the aorta. Studies have documented mortality rates for infected aortic grafts ranging from 25 to 75 percent, depending on the specific location in the aorta, how quickly treatment is initiated, and other patient factors.^[7] Thoracic aortic graft infections, those occurring in the chest portion of the aorta, have particularly high mortality rates in this range.^[7]

Among patients who survive graft infections, the burden of complications is substantial. As many as 75 percent of survivors of infected aortic grafts require amputation of at least one limb.^[1] For infections involving grafts in the legs, the rate of amputation is even higher, as preserving blood flow while removing infected material is often impossible.^[1]

The type of graft affects survival rates as well. Infections following endovascular stent-graft procedures, where grafts are placed through blood vessels using catheters rather than open surgery, have somewhat lower mortality rates around 25 percent, though they remain serious and life-threatening.^[7] These infections are also less common, occurring in fewer than 1 percent of endovascular procedures compared to higher rates with traditional open surgery.^[7]

It is important to understand that these statistics represent averages across many patients and many medical centers. Individual outcomes vary widely. Some patients respond well to treatment and recover fully, while others experience rapid deterioration despite aggressive care. Early recognition of symptoms, prompt diagnosis, and immediate treatment by experienced specialists offer the best chance for a favorable outcome.^[3]

#1 Clinical Trials Search in Europe